All Stories

  1. Four Facts Concerning Competition in US Generic Prescription Drug Markets
  2. Decline In Economic Returns From New Drugs Raises Questions About Sustaining Innovations
  3. The Hidden Cost Of Low Prices: Limited Access To New Drugs In India
  4. Economic Perspectives On The Advance Market Commitment For Pneumococcal Vaccines